Market Analysis
Evolving embolic protection devices providing practitioners with more options
Published in Blood Weekly, February 8th, 2007
Until recently, practitioners and their patients have had to deal with the uncertainty associated with complications due to procedure-related embolic events. For these patients, the evolving capabilities of embolic protection devices (EPD) have become an essential element in treatment decisions and therapeutic outcomes.
While the evolutionary success of embolic protection devises has been impressive, several...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-02-08)
More Articles from Blood Weekly
- Allergies
New allergy in children research from Research Hospital outlined - Central Nervous System Infection Epidemiology
New research on central nervous system infection epidemiology from Uppsala University summarized - Coagulation
Research from Central Hospital, Department of Medicine yields new findings on coagulation - Dengue Virus Cell Biology
Studies from University Hospital, Department of Pathology reveal new findings on dengue virus cell biology - Fibrinolysis
Research from Yuzuncu Yil University, Faculty of Medicine yields new data on fibrinolysis in children - Meningitis Genetics
Data on meningitis genetics detailed by researchers at University of Siena - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
